Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete‐ PsA).

Trial Profile

Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete‐ PsA).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Acronyms COMPLETE- PsA
  • Sponsors Abbott Canada; AbbVie
  • Most Recent Events

    • 17 Jul 2017 Planned End Date changed from 1 Jun 2020 to 30 Nov 2019.
    • 17 Jul 2017 Planned primary completion date changed from 1 Jun 2020 to 30 Nov 2019.
    • 15 Jul 2016 Planned End Date changed from 1 May 2018 to 1 Jun 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top